JUXTAPID — CHIESI, approved 2026-02-25 (NDA203858).
5,529 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.